Ministry of Health, Japan, grants priority review for PADCEV and KEYTRUD combination in first-line advanced...

Lantern Pharma progresses novel ADC program in various solid tumors

Dragonfly and Gilead to Explore DF1001 HER-2 TriNKET with Trodelvy in Cancer

AbbVie acquires ImmunoGen, including flagship ADC Elahere